MEDIROM Healthcare Technologies Inc. (
NYSE:MRM -
Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 495,900 shares, an increase of 57.4% from the August 15th total of 315,100 shares. Based on an average daily trading volume, of 2,580,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 16.8% of the shares of the company are short sold. Currently, 16.8% of the shares of the company are short sold. Based on an average daily trading volume, of 2,580,000 shares, the days-to-cover ratio is currently 0.2 days.
MEDIROM Healthcare Technologies Price Performance
NYSE:MRM traded down $0.10 during mid-day trading on Monday, reaching $1.80. The stock had a trading volume of 79,141 shares, compared to its average volume of 1,653,860. MEDIROM Healthcare Technologies has a twelve month low of $0.34 and a twelve month high of $5.30. The business has a 50 day simple moving average of $1.65 and a 200 day simple moving average of $1.22.
About MEDIROM Healthcare Technologies
(
Get Free Report)
MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MEDIROM Healthcare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MEDIROM Healthcare Technologies wasn't on the list.
While MEDIROM Healthcare Technologies currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.